Kate Furness1, Mary Anne Silvers2, June Savva3, Catherine E Huggins4, Helen Truby4, Terry Haines5. 1. Nutrition and Dietetics, Monash Health, Monash Medical Centre, 246 Clayton Rd, Clayton, VIC, 3168, Australia. kate.furness@monashhealth.org. 2. Nutrition and Dietetics, Monash Health, 246 Clayton Rd, Clayton, VIC, 3168, Australia. 3. Nutrition and Dietetics, Monash Health, 823-865 Centre Rd, Moorabbin, VIC, 3165, Australia. 4. Department of Nutrition Dietetics and Food, Monash University, Level 1 264 Ferntree Gully Rd, Notting Hill, VIC, 3168, Australia. 5. Allied Health Research Unit, Monash Health, Monash Medical Centre, 246 Clayton Rd, Clayton, VIC, 3168, Australia.
Abstract
PURPOSE: This study aimed to evaluate the long-term survival of all patients who participated in a pilot randomised trial of an early nutritional intervention for adults with upper gastrointestinal cancer. It also sought to identify factors that predicted patient mortality. METHODS:All participants (n = 21) who were randomised into the original study were followed for a maximum of 5 years and 2 months (final follow-up April 2016). The primary outcome measure was time from date of recruitment until date of death, ascertained by the Victorian Cancer Registry and/or Monash Health Scanned Medical Records. Secondary analyses were conducted to identify factors that adversely affected survival. RESULTS: At the end of the follow-up period, three patients were alive in the nutrition intervention group whilst only two patients were living from the standard care group. Visual evaluation of the Kaplan-Meier survival curves demonstrated a possible survival benefit from being exposed to the intervention between 6 months and 1.4 years post-recruitment, though this benefit dissipated soon after. The intervention was not associated with increased survival in univariate analyses, but was after adjustment for other factors found to adversely impact on survival (adjusted hazard ratio 0.12 (95% CI 0.02-0.72) p = 0.02). These factors were being a smoker (14.2 (1.43 to 140.67), p = 0.02); low baseline physical functioning (1.11 (1.01 to 1.21), p = 0.03); high baseline fatigue (1.09 (1.02-1.16), p = 0.007); and high baseline dyspnoea (1.08 (1.02-1.13), p = 0.003). CONCLUSION: Early and intensive nutrition intervention may increase the survival of people with upper gastrointestinal cancer.
RCT Entities:
PURPOSE: This study aimed to evaluate the long-term survival of all patients who participated in a pilot randomised trial of an early nutritional intervention for adults with upper gastrointestinal cancer. It also sought to identify factors that predicted patient mortality. METHODS: All participants (n = 21) who were randomised into the original study were followed for a maximum of 5 years and 2 months (final follow-up April 2016). The primary outcome measure was time from date of recruitment until date of death, ascertained by the Victorian Cancer Registry and/or Monash Health Scanned Medical Records. Secondary analyses were conducted to identify factors that adversely affected survival. RESULTS: At the end of the follow-up period, three patients were alive in the nutrition intervention group whilst only two patients were living from the standard care group. Visual evaluation of the Kaplan-Meier survival curves demonstrated a possible survival benefit from being exposed to the intervention between 6 months and 1.4 years post-recruitment, though this benefit dissipated soon after. The intervention was not associated with increased survival in univariate analyses, but was after adjustment for other factors found to adversely impact on survival (adjusted hazard ratio 0.12 (95% CI 0.02-0.72) p = 0.02). These factors were being a smoker (14.2 (1.43 to 140.67), p = 0.02); low baseline physical functioning (1.11 (1.01 to 1.21), p = 0.03); high baseline fatigue (1.09 (1.02-1.16), p = 0.007); and high baseline dyspnoea (1.08 (1.02-1.13), p = 0.003). CONCLUSION: Early and intensive nutrition intervention may increase the survival of people with upper gastrointestinal cancer.
Authors: Paul P Fahey; Kylie-Ann Mallitt; Thomas Astell-Burt; Glenn Stone; David C Whiteman Journal: Cancer Causes Control Date: 2015-07-26 Impact factor: 2.506
Authors: C Odelli; D Burgess; L Bateman; A Hughes; S Ackland; J Gillies; C E Collins Journal: Clin Oncol (R Coll Radiol) Date: 2005-12 Impact factor: 4.126
Authors: Mary Anne Silvers; June Savva; Catherine E Huggins; Helen Truby; Terry Haines Journal: Support Care Cancer Date: 2014-06-08 Impact factor: 3.603
Authors: Christine Baldwin; Marian Ae de van der Schueren; Hinke M Kruizenga; Christine Elizabeth Weekes Journal: Cochrane Database Syst Rev Date: 2021-12-21
Authors: Lauren Hanna; Catherine E Huggins; Kate Furness; Mary Anne Silvers; June Savva; Helena Frawley; Daniel Croagh; Paul Cashin; Liang Low; Judith Bauer; Helen Truby; Terrence Haines Journal: BMC Cancer Date: 2018-07-03 Impact factor: 4.430
Authors: Nicole Kiss; Brenton James Baguley; Kylie Ball; Robin M Daly; Steve F Fraser; Catherine L Granger; Anna Ugalde Journal: JMIR Mhealth Uhealth Date: 2019-02-12 Impact factor: 4.773
Authors: Kate Furness; Catherine E Huggins; Lauren Hanna; Mary Anne Silvers; Paul Cashin; Liang Low; Daniel Croagh; Terry P Haines Journal: BMC Cancer Date: 2018-11-29 Impact factor: 4.430